Mahesh Krishnan
Director · HALOZYME THERAPEUTICS, INC.
- 2025
- Jun 30, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mahesh Krishnan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Helen Torley - $42.15M in HALO purchases and sales in the last 12 months
- Matthew L. Posard - $2.61M in HALO purchases and sales in the last 12 months
- Cortney Caudill - $1.96M in HALO purchases and sales in the last 12 months
- Bernadette Connaughton - $699K in HALO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mahesh Krishnan?
Mahesh Krishnan is a corporate insider, tracked as Director of HALOZYME THERAPEUTICS, INC. (HALO). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Mahesh Krishnan last file a Form 4?
The most recent primary Form 4 on record is dated 30 June 2026, one of 3 filings going back to 2025.
Has Mahesh Krishnan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($548K) across all tracked filings.
